Wang et al. demonstrated that lncRNA A1BG-AS1 promotes adriamycin resistance in breast cancer cells by recruiting the m6A reader, Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), to stabilize ABCB1 mRNA, enhancing drug efflux and reducing apoptosis[61]. Here, ABCB1 is linked to breast cancer.